CN111394463B - 一种与甲状腺癌相关的分子及其应用 - Google Patents
一种与甲状腺癌相关的分子及其应用 Download PDFInfo
- Publication number
- CN111394463B CN111394463B CN202010319430.5A CN202010319430A CN111394463B CN 111394463 B CN111394463 B CN 111394463B CN 202010319430 A CN202010319430 A CN 202010319430A CN 111394463 B CN111394463 B CN 111394463B
- Authority
- CN
- China
- Prior art keywords
- rubcnl
- gene
- thyroid cancer
- detecting
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/713—Double-stranded nucleic acids or oligonucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010319430.5A CN111394463B (zh) | 2020-04-22 | 2020-04-22 | 一种与甲状腺癌相关的分子及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010319430.5A CN111394463B (zh) | 2020-04-22 | 2020-04-22 | 一种与甲状腺癌相关的分子及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111394463A CN111394463A (zh) | 2020-07-10 |
CN111394463B true CN111394463B (zh) | 2021-03-30 |
Family
ID=71433331
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010319430.5A Active CN111394463B (zh) | 2020-04-22 | 2020-04-22 | 一种与甲状腺癌相关的分子及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111394463B (zh) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101088089A (zh) * | 2004-02-23 | 2007-12-12 | 鹿特丹伊拉斯姆斯大学医疗中心 | 通过基因表达图形对急性粒细胞性白血病进行分类、诊断和预后 |
EP2559771A2 (en) * | 2007-05-17 | 2013-02-20 | Bristol-Myers Squibb Company | Biomarkers and methods for determining sensitivity to insulin growth factor-1 receptor modulators |
CN105543400A (zh) * | 2016-02-29 | 2016-05-04 | 北京泱深生物信息技术有限公司 | I型糖尿病的分子标志物 |
CN107002136A (zh) * | 2014-09-22 | 2017-08-01 | 格罗宁根大学 | ***的生物标记物 |
CN110129442A (zh) * | 2019-05-16 | 2019-08-16 | 中国人民解放军联勤保障部队第九六0医院 | 甲状腺癌的分子诊治标志物 |
-
2020
- 2020-04-22 CN CN202010319430.5A patent/CN111394463B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101088089A (zh) * | 2004-02-23 | 2007-12-12 | 鹿特丹伊拉斯姆斯大学医疗中心 | 通过基因表达图形对急性粒细胞性白血病进行分类、诊断和预后 |
EP2559771A2 (en) * | 2007-05-17 | 2013-02-20 | Bristol-Myers Squibb Company | Biomarkers and methods for determining sensitivity to insulin growth factor-1 receptor modulators |
CN107002136A (zh) * | 2014-09-22 | 2017-08-01 | 格罗宁根大学 | ***的生物标记物 |
CN105543400A (zh) * | 2016-02-29 | 2016-05-04 | 北京泱深生物信息技术有限公司 | I型糖尿病的分子标志物 |
CN110129442A (zh) * | 2019-05-16 | 2019-08-16 | 中国人民解放军联勤保障部队第九六0医院 | 甲状腺癌的分子诊治标志物 |
Non-Patent Citations (2)
Title |
---|
CD151 对甲状腺癌细胞迁移及侵袭能力的影响;吴勇军等;《现代生物医学进展》;20110630;第11卷(第11期);第2071-2074页 * |
Functional validation of putative tumor suppressor gene C13ORF18 in cervical cancer by Artificial Transcription Factors;Christian Huismana等;《MOLECULAR ONCOLOGY》;20130305;第7卷;第669-679页 * |
Also Published As
Publication number | Publication date |
---|---|
CN111394463A (zh) | 2020-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101711287B (zh) | 确定肝细胞癌亚型和检测肝癌干细胞的方法 | |
US7890267B2 (en) | Prognostic and diagnostic method for cancer therapy | |
US11053550B2 (en) | Gene-expression based subtyping of pancreatic ductal adenocarcinoma | |
CA2660857A1 (en) | Prognostic and diagnostic method for disease therapy | |
CN109468382B (zh) | lncRNA在肺腺癌诊疗中的应用 | |
CN108374048B (zh) | 一种用于诊断和治疗肝细胞癌的lncRNA标志物 | |
CN110331201B (zh) | 宫颈鳞癌相关生物标志物及其应用 | |
CN110628913A (zh) | 一种与乳腺癌相关的lncRNA标志物 | |
CN111996250B (zh) | 用于开发胃腺癌诊疗产品的分子标志物 | |
CN110628914B (zh) | 与乳腺癌相关的lncRNA标志物及其检测引物和应用 | |
CN108998532B (zh) | 一种直肠腺癌的诊治标志物 | |
EP2550534B1 (en) | Prognosis of oesophageal and gastro-oesophageal junctional cancer | |
CN108660211B (zh) | 一种与肝细胞癌相关的生物标志物linc01549及其应用 | |
CN111394463B (zh) | 一种与甲状腺癌相关的分子及其应用 | |
CN108384858B (zh) | 肺癌相关基因及其在肺癌诊治中的应用 | |
CN107893119B (zh) | Zcchc12在骨肉瘤中的应用 | |
CN111394461B (zh) | 宫颈鳞癌的分子靶标及其在诊断和治疗中的应用 | |
CN111424092A (zh) | 一种检测基因及其应用 | |
CN110592218B (zh) | 一种诊治乳腺癌的生物标志物 | |
CN111440867B (zh) | 生物标志物在肝癌诊断和治疗中的应用 | |
CN116790760B (zh) | 结肠癌特异性环状rna标记物及其检测引物与应用 | |
CN111394459B (zh) | 宫颈鳞癌的生物标志物nxn及其在诊疗中的应用 | |
CN109971854B (zh) | 用于开发宫颈疾病的诊疗产品的靶分子 | |
CN108085393A (zh) | 肾透明细胞癌相关生物标志物及其应用 | |
CN108866198B (zh) | 标志物loc105376380在直肠腺癌诊断和治疗中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Zhang Cong Inventor after: Xue Guoliang Inventor after: Li Meiye Inventor before: Xue Guoliang Inventor before: Li Meiye Inventor before: Zhang Cong |
|
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Zhang Cong Inventor after: Li Meiye Inventor after: Xue Guoliang Inventor before: Zhang Cong Inventor before: Xue Guoliang Inventor before: Li Meiye |
|
CB03 | Change of inventor or designer information | ||
GR01 | Patent grant | ||
GR01 | Patent grant |